Search

Natalia P Ulyanova

from Brookline, MA
Age ~47
Get Report
Also known as:
Natalya Ulyanova
Connected to:
Danila Ulyanov, 43Ilya Ulyanov, 50Kirill Ulyanov, 42Bodelais Ulysse, 63Danielle C Ulysse, 37Jessica S Ulysse, 36Martin Ulysse, 36Viviane Ulysse, 46Anthony G Ulysses, 35Robert J Ulz, 57

Natalia Ulyanova Phones & Addresses

  • Brookline, MA
  • Brighton, MA
  • Malden, MA
  • Somerville, MA
  • Falmouth, MA
  • Dracut, MA

Resumes

Resumes

Natalia Ulyanova Photo 1

Natalia Ulyanova

Industry:
Recreational Facilities And Services
Natalia Ulyanova Photo 2

Business Development Director, Oncology

Location:
1 Memorial Dr, Cambridge, MA 02142
Industry:
Biotechnology
Work:
Metamark Genetics, Inc - Cambridge MA since Jun 2011
Business Development Manager
Simmons College Jan 2010 - Dec 2011
Biology Instructor
Massachusetts College of Pharmacy and Health Sciences Sep 2010 - May 2011
Biology and Chemistry Instructor
Brigham and Women's Hospital Jan 2007 - Feb 2010
Postdoctoral Fellow
Education:
Tufts University School of Medicine 2000 - 2006
PhD, Biochemistry Novosibirsk State University (NSU) 1994 - 1999
BS and MS, Chemistry
Skills:
Licensing
Negotiation
Project Management
Molecular Biology
Assay Development
Biology
Biochemistry
Lifesciences
Biotechnology
Cell Culture
Elisa
Molecular Cloning
Cell Biology
Biomarkers
Drug Discovery
Small Molecules
Business Development
Intellectual Property
Competitive Intelligence
Cell Based Assays
Antibodies
Oncology
Cell
Life Sciences
Medical Devices
Pharmaceutical Industry

Publications

Us Patents

Beta-Carbolines As Inhibitors Of Haspin And Dyrk Kinases

US Patent:
20130231360, Sep 5, 2013
Filed:
Apr 21, 2011
Appl. No.:
13/639684
Inventors:
Jonathan Higgins - Chestnut Hill MA, US
Debasis Patnaik - Quincy MA, US
Natalia Ulyanova - Brookline MA, US
Ross L. Stein - Cambridge MA, US
Jun Xian - Sharon MA, US
Marcie Glicksman - Winchester MA, US
Gregory D. Cuny - Houston TX, US
Assignee:
THE BRIGHAM AND WOMEN S HOSPITAL, INC. - Boston MA
International Classification:
C07D 471/04
C07D 209/56
US Classification:
514287, 546 86, 514292, 548440, 514411, 546 65, 546 87
Abstract:
The present disclosure is directed to compounds of Formula (I) which are inhibitors of Haspin kinase and DYRK kinases. The compounds of the present disclosure, and compositions thereof, are useful in the treatment of disease related to Haspin kinase and DYRK kinase expression and/or activity.
Control profile
Natalia P Ulyanova from Brookline, MA, age ~47 Get Report